Conquis Financial LLC Acquires Shares of 1,926 Intuitive Surgical, Inc. $ISRG

Conquis Financial LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,926 shares of the medical equipment provider’s stock, valued at approximately $1,091,000. Intuitive Surgical accounts for 0.9% of Conquis Financial LLC’s investment portfolio, making the stock its 14th biggest holding.

Several other institutional investors have also modified their holdings of the stock. Holos Integrated Wealth LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $25,000. Newbridge Financial Services Group Inc. raised its stake in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Olistico Wealth LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $28,000. Caitlin John LLC purchased a new position in Intuitive Surgical during the third quarter worth about $30,000. Finally, Laurel Wealth Advisors LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $31,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.8%

ISRG stock opened at $422.06 on Friday. The business has a 50 day moving average price of $447.24 and a 200 day moving average price of $501.02. The stock has a market cap of $149.48 billion, a price-to-earnings ratio of 51.16, a PEG ratio of 3.37 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s revenue was up 23.0% on a year-over-year basis. During the same period last year, the firm posted $1.81 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research analyst reports. Leerink Partners reduced their price target on shares of Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 22nd. BTIG Research reissued a “buy” rating and issued a $574.00 price target on shares of Intuitive Surgical in a research note on Wednesday, April 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research note on Wednesday, March 11th. Finally, Bank of America reduced their price target on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $573.63.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 7,448 shares of company stock valued at $3,224,404. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.